All issues > Volume 47(12); 2004

Clinical Lecture

Korean J Pediatr. 2004;47(12):1262-1265. Published online December 15, 2004.

Treatment of Immue Thrombocytopenic Purpura in Childhood

Hwang Min HM Kim¹

¹Department of Pediatrics, Yonsei University Wonju College of Medicine, Wonju, Korea

Abstract

Childhood immune thrombocytopenic purpura(ITP) is a typically benign self-limiting bleeding disorder of not fully known autoimmune etiology. Chronic ITP, which is defined by duration of more than 6 months, occurs in approximately 20% of children. Neither the risk of bleeding nor the type of disease, acute or chronic, can be predicted at initial presentation. The indication of treatment, choice of treatment in various clinical conditions are still controversial. In this review, we tried to summarize the indication, mechanism and application of various kinds of treatments in childhood ITP.

Keywords :Immune thrombocytopenic purpura, Childhood, Treatment